Phase II study of liposomal doxorubicin in refractory...

Journal of Clinical Oncology 1997 / 03 Vol. 15; Iss. 3

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

Muggia, F M, Hainsworth, J D, Jeffers, S, Miller, P, Groshen, S, Tan, M, Roman, L, Uziely, B, Muderspach, L, Garcia, A, Burnett, A, Greco, F A, Morrow, C P, Paradiso, L J, Liang, L J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.1997.15.3.987
Date:
March, 1997
File:
PDF, 617 KB
english, 1997
Conversion to is in progress
Conversion to is failed